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The reaction of LnCl3·6H2O with (S)-(+)-2-(6-methoxy-2-naphthyl)propionic acid (S-HL), best known 32 
as naproxen, and 1,10-phenanthroline (phen) in EtOH allows the isolation of dinuclear chiral 33 
compounds S-1–4 of the formula [Ln2(S-L)6(phen)2]·3DMF·H2O [Ln(III) = Eu (1), Gd (2), Tb (3) and 34 
Dy (4)]. The use of the R-enantiomeric species of the HL ligand led to complexes R-1–4 with the 35 
formula [Ln2(R-L)6(phen)2]·3DMF·H2O. Compounds R- and S-1, 3 and 4 show strong sensitized 36 
metal-centred luminescence in the visible region. Moreover, Dy(III) complexes R- and S-4 display field-37 
induced singlemolecule magnet (SMM) behaviour. For chiral and emissive compounds circularly 38 




The (S) enantiomer of 2-(6-methoxi-2-naphthyl)propionic acid, best known as naproxen, is one of the 43 
most used non-steroidal anti-inflammatory drugs (NSAID) nowadays. Belonging to the phenylalkanoic 44 
acid group of NSAIDs, naproxen presents analgesic and antipyretic properties1 and is commonly used to 45 
treat inflammatory diseases such as rheumatoid arthritis, spondylitis and osteoarthritis.2 Moreover, both 46 
the R- and S-enantiomeric species of 2-(6-methoxi-2-naphthyl)propionic acid are able to coordinate to 47 
metal ions through the carboxylate group. A few examples of chiral coordination compounds with 48 
naproxen and transition metals such as Cu(II),3–10 Co(II),11 Ni(II),12 Zn(II),10,13,14 Ag15 and 49 
Cd(II)10 can be found in the literature, showing bioactive,5 antioxidant16 or optical and ferroelectric 50 
properties,10 the latter derived from the chirality induced by the carboxylate. Only Conclusions three 51 
lanthanide coordination complexes containing naproxen and 1,10-phenanthroline (phen) with the 52 
formula [Ln2(SL1) 6(phen)2] where Ln = Gd(III), Dy(III) and Er(III) have been previously reported.17 53 
Moreover, to the best of our knowledge, there are no reported lanthanide coordination complexes 54 
containing the R-2-(6-methoxi-2-naphthyl)propionate enantiomer.  55 
Due to the wide medical applications of NSAIDs it is necessary to develop simple methods to detect 56 
their presence in biofluids and in wash-offs from pharmaceutical equipment in its cleaning.18 For this 57 
purpose, it is useful to take advantage of the characteristic emissions of Ln(III) metal ions, mainly from 58 
Eu(III) and Tb(III), sensitized via ligand-to-metal energy transfer processes best known as the “antenna 59 
effect”.19,20 Consequently, organic ligands coordinated to Ln(III) ions must have chromophore groups 60 
such as in the case of these anti-inflammatory species. 61 
Moreover, luminescent lanthanide complexes have presentday applications in materials and biosciences 62 
fields.21–25 The addition of chiral properties through the use of enantiomerically pure ligands in these 63 
kinds of complexes allows their potential use as nonlinear or circularly polarized luminescent materials, 64 
a field currently in upswing.26–29 The reported examples of chiral lanthanide complexes are mainly of 65 
monoand dinuclear structures.29–33 66 
Chiral ligands induce chiroptical properties to the f–f transitions of Ln(III) ions. In emission these 67 
properties can be measured by the circularly polarized luminescence (CPL) technique, which can be 68 
quantified by means of the dissymmetry factor glum (eqn (1)) where IL and IR correspond to the left 69 
and right circularly polarized components of the emission. 70 
 71 
 (1) 72 
 73 
Based on previously reported CPL measurements, glum factors are about 10−4–10−3 for non-aggregate 74 
organic molecules and for transition metal complexes.34 Meanwhile for Ln(III) complexes this 75 
parameter increases up to 10−1–1.29,35–37  76 
On the other hand, Ln(III) ions are ideal candidates to form complexes that can behave as single-77 
molecule magnets (SMMs)38 with potential applications in spintronics,39 high density data storage,40 78 
and quantum computing.41 SMMs show slow relaxation of the magnetization with an energy barrier 79 
(Ea) proportional to the local anisotropy of the Ln(III) ions that prevents the spin reversal.42 Since 80 
Ln(III) ions present, in general, strong spin–orbit coupling, their intrinsic magnetic anisotropy is 81 
extremely sensitive to the shape and nature of the ligand field around the ion.43 82 
With the aim of obtaining new compounds in which chiral, magnetic and luminescence properties 83 
coexist, we present herein the structural, magnetic and optical studies of eight new chiral lanthanide 84 
coordination complexes derived from the use of the pure enantiomeric R- or S-species of 2-(6-methoxi-85 
2-naphthyl)propionic acid (R- and S-HL respectively) and the auxiliary ligand 1,10-phenanthroline 86 
(phen). Therefore, here we present the first examples of Ln(III) coordination complexes with the R-HL 87 
ligand. Neutral chelating phen ligands can block two coordination sites per Ln(III) ion and terminate 88 
further aggregation or potential polymerization. 44 In addition, phen ligands can also act as an efficient 89 
antenna to sensitise the luminescence of the lanthanide ions. The enantiomeric pairs of complexes R/S-90 
1–4 show the same molecular formula [Ln2(R-L)6(phen)2]·3DMF·H2O for Ln(III) = Eu (R-1), Gd (R-91 
2), Tb (R-3) and Dy (R-4) and [Ln2(S-L)6(phen)2]·3DMF·H2O for Ln(III) = Eu (S-1), Gd (S-2), Tb (S-92 
3) and Dy (S-4). It is worth mentioning that these compounds have been obtained at room temperature 93 
and pressure, even though Ln(III) coordination compounds are often synthesised via solvothermal 94 
methods.17,45–47 95 
The previously reported Gd(III) and Dy(III) coordination compounds with naproxen present the same 96 
dinuclear unit formula [Ln2(S-L)6(phen)2] as S-2 and S-4 but a different crystal structure, without 97 
solvent molecules.17 Structural studies based on single crystal XRD over the already published Gd(III) 98 
and Dy(III) compounds and on powder X-ray diffraction (PXRD) over the Er(III) compound revealed 99 
that the Ln(III) ions inside the dinuclear units are octa-coordinated and they are bridged through four 100 
carboxylate ligands in a syn–syn coordination mode. Meanwhile, in R- and S-1–4 the carboxylate 101 
ligands present two different coordination modes, two bridging syn–syn carboxylate groups and two 102 
chelating-bridging carboxylate groups, and the Ln(III) ions are nonacoordinated. Magnetic studies on 103 
the previously published complexes showed field-induced SMM behaviour for the Dy(III) complex with 104 






Experimental section 111 
Starting materials 112 
LnCl3·6H2O salts [Ln(III) = Eu, Tb, Dy (Strem Chemicals), Gd (Aldrich)], (S)-(+)-2-(6-methoxy-2-113 
naphthyl)propionic acid (TCI), (R)-(−)-2-(6-methoxy-2-naphthyl)propionic acid (Aldrich), KOH 114 
(Aldrich) and 1,10-phenantroline (Aldrich) were used as received without further purification. 115 
 116 
Spectral and magnetic measurements 117 
The elemental analyses of the compounds were performed at the Serveis Científics i Tecnològics of the 118 
Universitat de Barcelona. Infrared spectra (4000–400 cm−1) were recorded from KBr pellets on a 119 
PerkinElmer 380-B spectrophotometer. Solid state fluorescence spectra were recorded on a Horiba Jobin 120 
Yvon SPEX Nanolog fluorescence spectrophotometer at room temperature. 121 
CPL spectra were recorded at the Università di Pisa with a home-built CPL spectrofluoropolarimeter 122 
under UV irradiation (λmax = 365 nm) on quartz plate depositions. The depositions of the complexes 123 
were obtained from CH3CN dispersions. CH3CN was chosen as a dispersant because it is a poor solvent 124 
for compounds S- and R-1, 3 and 4, in this way the complexes are not dissolved during the casting. In 125 
order to rule out the occurrence of contributions from linear dichroism/linear birefringence, different 126 
spectra recorded after rotating the sample by 90° around the optical axis or around an axis perpendicular 127 
to the optical axis were recorded and compared; all the spectra were averaged. 128 
ECD spectra were recorded at the Università di Pisa with a Jasco J-710 spectropolarimeter on the same 129 
samples of compounds S- and R-1, 3 and 4, used for CPL measurements. Several spectra were acquired 130 
rotating the sample as described above for CPL. 131 
Magnetic measurements were performed on solid polycrystalline samples in a Quantum Design MPMS-132 
XL SQUID magnetometer at the Magnetic Measurements Unit of the Universitat de Barcelona. Pascal’s 133 
constants were used to estimate the diamagnetic corrections, which were subtracted from the 134 
experimental susceptibilities to give the corrected molar magnetic susceptibilities. 135 
 136 
X-ray crystallography 137 
Single-crystals of complexes R- and S-1, 3 and 4 were mounted in air on a D8VENTURE (Bruker) 138 
diffractometer with a CMOS detector. The crystallographic data, conditions retained for the intensity 139 
data collection and some features of the structure refinements are listed in Table S1.† All the structures 140 
were refined by the least-squares method. Intensities were collected with a multilayer monochromated 141 
Mo-Kα radiation. Lorentz polarization and absorption corrections were made in all the samples. The 142 
structures were solved by direct methods, using the SHELXS-97 computer program,48 and refined by 143 
the fullmatrix least-squares method, using the SHELXL-2014 computer program.49 The non-hydrogen 144 
atoms were located in successive difference Fourier syntheses and refined with aniso-tropic thermal 145 
parameters on F2. For hydrogen atoms, isotropic temperature factors have been assigned 1.2 or 1.5 times 146 
the respective parent.  147 
 148 
General syntheses 149 
Solvothermal methods have been extensively used to synthesise polymeric compounds with diverse 150 
interesting structures although the mechanism is not completely clear so far. In fact, previously 151 
published compounds with the formula [Ln2(R-L)6(phen)2] were obtained through solvothermal 152 
synthesis. 17 So, in our experiment, we use a straightforward ambient temperature and pressure 153 
procedure. The preparation of compounds R- and S-1–4 was achieved via the reaction of the 154 
corresponding enantiomerically pure R/S-2-(6-methoxy-2-naphthyl)propionic acid (R/S-HL,1.5 mmol, 155 
0.345 g) with 1.5 mmol (0.084 g) of KOH dissolved in 15 mL of MeOH. The mixture was stirred for 156 
one hour. After this, a solution of 1,10-phenantroline (phen, 0.3 mmol, 0.054 g) in 10 mL of MeOH and 157 
another containing the corresponding LnCl3·6H2O salt (0.25 mmol; 0.092 g for Ln = Eu, 0.093 g for Ln 158 
= Gd, 0.093 g for Ln = Tb and 0.094 g for Ln = Dy) in 5 mL of DMF were added. The resulting mixture 159 
was stirred for another hour at room temperature. R-HL and Ln = Eu for R-1, S-HL and Ln = Eu for S-1, 160 
R-HL and Ln = Gd for R-2, S-HL and Ln = Gd for S-2, R-HL and Ln = Tb for R-3, S-HL and Ln = Tb 161 
for S-3, R-HL and Ln = Dy for R-4, and S-HL and Ln = Dy for S-4. Good crystals suitable for X-ray 162 
analysis of complexes R/S-1, 3 and 4 were obtained after one month of slow evaporation. Meanwhile, 163 
for complexes R/S-2 polycrystalline solids were obtained. Anal.Calc. (%) for S-1 C, 61.71; H, 5.18; N, 164 
4.30. Found: C, 61.2; H, 5.2; N, 4.2, calc. (%) for R-1 C, 61.71; H, 5.18; N, 4.30. Found: C, 61.6; H, 5.3; 165 
N, 4.4, calc. (%) for S-2 C, 61.43; H, 5.15; N, 4.28. Found: C, 61.5; H, 5.2; N, 4.3, calc. (%) for R-2 C, 166 
61.43; H, 5.15; N, 4.28. Found: C, 61.4; H, 5.2; N, 4.3, calc. (%) for S-3 C, 61.43; H, 5.15; N, 4.28. 167 
Found: C, 61.2; H, 5.1; N, 4.3, calc. (%) for R-3 C, 61.34; H, 5.15; N, 4.28. Found: C, 61.3; H, 5.2; N, 168 
4.3, calc. (%) for S-4 C, 61.14; H, 5.13; N, 4.27. Found: C, 60.9; H, 5.1; N, 4.2, calc. (%) for R-4 C, 169 
61.14; H, 5.13; N, 4.27. Found: C, 61.0; H, 5.0; N, 4.3. Selected IR bands (KBr pellet, cm−1): 3454 (m), 170 
3047–2827 (s), 1673 (m), 1632 (s), 1604 (vs), 1589 (s), 1550 (s), 1486 (m), 1460 (m), 1426 (m) for S-1, 171 
3444 (m), 3047–2819 (m), 1673 (vs), 1633 (s), 1603 (vs), 1587(s), 1556 (s), 1486 (m), 1462 (vs), 1425 172 
(s) for R-1, 3419 (m), 3047–2835 (m), 1673 (s), 1635 (s), 1604 (vs), 1589 (s), 1558 (m), 1486 (m), 1458 173 
(m), 1425 (s) for S-2, 3443 (m), 3047–2835 (m), 1671 (s), 1631 (s), 1603 (vs), 1584 (s), 1553 (m), 1485 174 
(m), 1456 (m), 1423 (m) for R-2, 3446 (m), 3057–2838 (s), 1673 (s), 1633 (s), 1604 (s), 1589 (s), 1553 175 
(s), 1486 (s), 1450 (s), 1426 (s) for S-3, 3448 (m), 3057–2835 (s), 1672 (s), 1631 (s), 1604 (vs), 1588 176 
(s), 1552 (s), 1482 (m), 1460 (m), 1425 (s) for R-3, 3443 (m), 3055–2827 (s), 1671 (s), 1633 (m), 1604 177 
(vs), 1588 (m), 1554 (m), 1485 (m), 1459 (m), 1425 (s) for S-4 and 3443 (m), 3047–2835 (s), 1671 (s), 178 
1633 (m), 1604 (vs), 1585 (m), 1554 (m), 1485 (s), 1459 (m), 1425 (s) for R-4. 179 
 180 
Results and discussion 181 
X-ray crystal structures 182 
Single-crystal X-ray analysis of complexes R- and S-1, 3 and 4 reveals that all the complexes crystallize 183 
in the non-centrosymmetric triclinic P1 space group (Table S1†). The asymmetric unit of R- and S-1, 3 184 
and 4 is formed by [Ln2(R/S-L)6(phen)2]·3DMF·H2O units. Based on the elemental analysis and the 185 
infrared and powder XRD spectra (Fig. S1†), it is proposed that complexes R- and S-2 are isostructural 186 
to the rest of the obtained complexes. Besides the optical isomerism, R- and S-1–4 exhibit the same 187 
structure with only slight differences in the structural parameters due to the incremental ionic radius and 188 
thus only the structure of compound S-3 will be discussed.  189 
[Tb2(S-L)6(phen)2]·3DMF·H2O (S-3). A labelled plot of the structure of the dinuclear fragment of 190 
compound S-3 is represented in Fig. 1a. Selected bond distances for R- and S-1, 3 and 4 are listed in 191 
Table 1. The structure consists of dinuclear molecules in which each Tb(III) is nona-coordinated. 192 
In each unit the two Tb(III) atoms are bridged through four deprotonated carboxylate S-L ligands. There 193 
are two different kinds of coordination modes for the carboxylate ligands. One bridging carboxylate in 194 
the coordination mode μ-1κO:2κO′ with the bond lengths Tb1–O1, Tb1–O5, Tb2–O2, and Tb2–O6 195 
being 2.339(5), 2.353(5), 2.356(5) and 2.367(5) Å, respectively. The second kind of bridging 196 
coordination mode of the carboxylate is μ-1κ(O,O′):2κ(O′), in which O3 and O7 act as bridges between 197 
the two Tb atoms with distances of 2.499(5) for Tb1–O3, 2.348 (5) Å for Tb2–O3, 2.335(5) for Tb1–O7 198 
and 2.552(5) Å for Tb2–O7, meanwhile O4 and O8 are bonded only to one Tb(III) atom with distances 199 
for Tb1–O4 and Tb2–O8 of 2.478(5) and 2.461(5) Å respectively. The Tb1⋯Tb2 distance is 3.917(4) Å. 200 
The coordination sphere of each metal is completed by two N atoms of a 1,10-phenanthroline ligand 201 
with bond lengths of  Tb1–N1, Tb1–N2, Tb2–N3 and Tb2–N4 of 2.618(6), 2.548(5), 2.582(7) and 202 
2.581(7) Å, respectively, and by the two oxygen atoms of a chelating L carboxylate ligand in the 203 
κ(O,O′) coordination mode with bond lengths for Tb1–O9, Tb1–O10, Tb2–O11 and Tb2–O12 of 204 
2.410(5), 2.496(5), 2.484(6) and 2.443(6) Å, respectively. The shortest Tb⋯Tb intermolecular distance 205 
in the complex S-3 is 9.840(1) Å and corresponds to Tb1⋯Tb2′ (′:1 +x,y,z), the rest of the shortest 206 
Ln⋯Ln intermolecular distances are collected in Table S2.† 207 
Systematic analysis of the coordination geometries around the metals using SHAPE 2.1 reveals that 208 
LnN2O7 arrangements for R- and S-1, 3 and 4 are intermediate between various coordination polyhedra 209 
geometries (Table S3 in the ESI†). The lowest shape measures for S-3 correspond to Muffin (MFF-9) 210 
and spherical capped square antiprism (CSAPR-9) with values of 1.151 and 1.529 for Tb1 and 1.464 and 211 
1.613 for Tb2, respectively. In Fig. 1b the coordination sphere of the Tb(III) ions in the S-3 compound is 212 
shown. 213 
Three DMF molecules and one water molecule co-crystallize with complexes R- and S-1, 3 and 4. The 214 
interaction of the water molecule with the dinuclear entities via a hydrogen bond depends on the 215 
enantiomer. Therefore, for the enantiomeric species derived from the S-HL, the atom H1W of the water 216 
molecule is bonded by the oxygen O11 from one of the chelating S-L ligands. On the other hand, for the 217 
R-species of complexes 1, 3 and 4 the water molecule interacts with the O9 oxygen atom from the other 218 
terminal R-L ligand. In both enantiomeric isomers the water molecule forms another hydrogen bond 219 
with one of the oxygen atoms from a DMF molecule (Fig. S2†). The structural parameters for these 220 
supramolecular contacts in R- and S-1, 3 and 4 are summarized in Table S4.† 221 
All compounds R- and S-1, 3 and 4 show intermolecular π-stacking interactions between the aromatic 222 
rings of the phen auxiliary ligands containing the N1 and N2 nitrogen atoms with the ones containing 223 
the N3 and N4 nitrogen atoms from an adjacent dinuclear entity. These supramolecular interactions 224 
result in a 1D supramolecular structure along the [100] direction, represented in Fig. S3.† The structural 225 
parameters of these contacts are summarized in Table S5.†  226 
Lanthanide contraction on compounds R- and S-1, 3 and 4 is confirmed by the diminution of Ln(III)–O 227 
and Ln(III)–N bond lengths and also on Ln1⋯Ln2 intramolecular distances. 228 
The analysis of the structural parameters between each enantiomeric pair reveals that the differences 229 
between the hydrogen bonds promote shorter Ln1–O distances compared to the Ln2–O ones and more 230 
opened angles for Ln1–O3–Ln2 than for Ln1–O7–Ln2 in the S-enantiomers. These observed tendencies 231 
are reversed for the R-enantiomeric species. 232 
If we compare the structure of S-2 and S-4 with the previously reported Gd(III) and Dy(III) coordination 233 
compounds derived from naproxen, they present the same dinuclear unit formula [Ln2(S-L)6(phen)2] 234 
but a different crystal structure and solvent molecules. Structural studies based on single crystal XRD 235 
over the already published Gd(III) and Dy(III) compounds and on powder X-ray diffraction (PXRD) 236 
over the Er(III) compound revealed that the Ln(III) ions inside the dinuclear units are octa-coordinated 237 
and they are bridged through four carboxylate ligands in a μ-1κO:2κO′ coordination mode. Meanwhile, 238 
in R- and S-1–4 the carboxylate ligands present two different bridging coordination modes, two bridging 239 
μ-1κO:2κO′ carboxylate groups and two μ-1κ(O,O′):2κ(O′) carboxylate groups and the Ln(III) ions are 240 
nonacoordinated. This change of coordination is reflected in the magnetic properties of the complexes. 241 
 242 
Magnetic properties 243 
Due to the identical magnetic behaviour between the R- and S-enantiomers of complexes 1–4, solid-244 
state direct-current (dc) magnetic susceptibility (χM) measurements were performed only on one of the 245 
corresponding enantiomers. Powder samples of complex S-1 were measured under an applied magnetic 246 
field of 0.5 T (300–2.0 K) and 0.3 T (300–2 K) for complexes S-2, S-3 and S-4. The data are plotted as 247 
χMT products versus T in Fig. 2a. Magnetization dependence on the applied field at 2 K for compounds 248 
S-1, S-2, S-3 and S-4 was also recorded and is shown in Fig. 2b. 249 
Room-temperature values of χMT are 2.81 (S-1), 16.18 (S-2), 23.69 (S-3) and 28.62 (S-4) cm3 mol−1 250 
K. Based on the expected values for two isolated Ln(III) ions, the following χMT values were 251 
calculated:50 Eu(III) ground state 7F0, χMTcalcd = 0 cm3 K mol−1; Gd(III) ground state 8S7/2, gJ = 2, 252 
χMTcalcd = 15.75 cm3 K mol−1; Tb(III) ground state 7F6, gJ = 3/2, χMTcalcd = 23.64 cm3 K mol−1; 253 
Dy(III) ground state 6H15/2, gJ = 4/3, χMTcalcd = 28.34 cm3 K mol−1. The experimental χMT values 254 
are in good agreement with the calculated ones, except for compound 1. Although the magnetic ground 255 
state of Eu(III) is 7F0, a non-zero experimental value of χMT ≈ 2.81 cm3 K mol−1 is observed because 256 
of the second-order effect due to Zeeman-induced mixing of the close-lying excited state in the ground 257 
state.51 258 
The thermal dependence of χMT varies in function of the Ln(III) ion. For compound S-1 the value of the 259 
χMT product decreases gradually on cooling, reaching a value of 0.03 cm3 mol−1 K. The nearly zero 260 
χMT value for the Eu(III) compound S-1 at 2 K confirms the stabilization of the ground state J = 0. To 261 
calculate the spin–orbit coupling parameter, λ, the compound S-1 was considered as formed by two non-262 
magnetically coupled Eu(III) ions. The spin–orbit coupling operator is:52,53 263 
 264 





The best fitting value parameter obtained by using eqn (2) was λ = 341 cm−1. 270 
For the dinuclear Gd(III) compound S-2, the χMT product remains almost constant down to ∼20 K and 271 
then decreases to 12.87 cm3 mol−1 K at 2.0 K, suggesting a moderately weak antiferromagnetic 272 
exchange interaction. For this complex, fitting of the experimental data was performed by means of eqn 273 
(3) using the PHI computer program.54 The best-fit parameters obtained were J = −0.03 cm−1 and g = 274 
2.03 with R = 4.18 × 10−5, confirming the existence of an antiferromagnetic coupling between the metal 275 
centres. The J value is comparable with those found for similar Gd(III) homodinuclear compounds.44,55 276 
 277 
 278 
For Tb(III) (S-3) and Dy(III) (S-4) compounds the value of the χMT product remains almost constant 279 
down to ∼50 K and then decreases to 20.25 cm3 mol−1 K at 7.0 K for S-3 and to 23.63 cm3 mol−1 K at 280 
6 K for S-4. From these temperatures the χMT values fall on cooling reaching values of 15.74 cm3 281 
mol−1 K and 18.62 cm3 mol−1 K for S-3 and S-4, respectively, at 2 K. Magnetization dependence on 282 
the applied static magnetic field at T = 2 K for complexes S-1, S-2, S-3 and S-4 (Fig. 2b) reveals 283 
saturation at high fields only in the case of the Gd(III) complex S-2, with a value of 14.38 NμB at 5T. 284 
 285 
Ac magnetic susceptibility studies 286 
For compounds S-3 and S-4 dynamic magnetic studies were performed in order to study if they show 287 
SMM behaviour. The measurements, under an ac magnetic field of 4 × 10−4 T, reveal that at zero static 288 
external magnetic field none of the complexes show in-phase (χ′M) and/or out-of-phase (χ″M) ac 289 
susceptibility signals under frequencies up to 1488 Hz. This fact may indicate low magnetic anisotropy 290 
or that the quantum tunnelling of the magnetization (QTM) process dominates the magnetization 291 
relaxation time (τ), but this relaxation path can be suppressed (or partially suppressed) at low 292 
temperatures when a static magnetic field is applied.56 293 
In the case of compound S-3 even under an applied dc field of 0.15 T no frequency or thermal 294 
dependency of χ′M and/or χ″M is observed. 295 
For complex S-4 the frequency dependence of χ″M under a zero applied static dc field indicates no 296 
maximum in the signal. Under a non-zero field, compound S-4 reveals temperature dependent peaks in 297 
the presence of a 0.2 T dc field, in the temperature range of 1.8–7.0 K (Fig. S4†). 298 
Ac susceptibility frequency dependences of both χ′M and χ″M at temperatures between 1.8–3.2 K were 299 
analysed using the Cole–Cole Model (Fig. 3b, Table S6†).57 The alpha parameter is a bit high 300 
suggesting that there is likely to be more than one relaxation process operating at low temperatures.58 301 
Temperature dependence of the relaxation times (τ) (Fig. 3c) follows the Arrhenius law [τ = τ0 302 
exp(Ueff/kBT)], giving an energy barrier (Ueff) of 4.2 cm−1 and a pre-exponential factor (τ0) of 4.9 × 303 
10−5 s. As the Ueff value is so low, we suppose a contribution of a direct process following the 304 
equation: τ−1 = τ0 −1 exp(Ueff/kBT) + AT. The best fit parameters are: Ueff = 4.4 cm−1, τ0 = 4.6 × 305 
10−5 s, and A = 45 s−1 K−1. The energy barrier obtained is small, but comparable to that of other 306 
dinuclear dysprosium complexes reported in the literature.59,60  307 
On the other hand, the relaxation values obtained for S-4 differ significantly from those of the 308 
previously reported Dy(III) S-L complex (Ueff = 12 cm−1, τ0 = 2.7 × 10−6 s),17 but this is not 309 
surprising because the Dy(III) ions in each complex present different coordination spheres: in S-4 the 310 
Dy(III) ions are nonacoordinated and in the previous complex they are octacoordinated and thus S-4 311 
shows a different crystal-field. 312 
 313 
Photo-physical studies 314 
Luminescence studies 315 
Solid-state luminescence properties of complexes R- and S-1–4 were studied at room temperature. Since 316 
all the enantiomeric pairs present the same luminescent response, only one enantiomer will be discussed 317 
(Fig. 4). 318 
The emission spectrum of S-Eu(III) (S-1), measured at λex = 355 nm (Fig. 4a), shows the sensitization 319 
of the 5D0 → 7FJ transitions at 577 nm ( J = 0), 591 nm ( J = 1), 614 nm ( J = 2), 650 nm ( J = 3) and 320 
697 nm ( J = 4). The 5D0 → 7F0 magnetically allowed transition shows only one band, suggesting the 321 
existence of only one coordination environment for the Eu(III) ions in S-1.29,61 The dominant 5D0 → 322 
7F2 transition shows signs of splitting due to the ligand field around the ions. This splitting is also 323 
observed in the 5D0 → 7F4 transition. It is not possible to observe ligand emission down to 500 nm and 324 
therefore, the energy transfer from the ligand to the metal seems to be high. The excitation spectrum 325 
measured at λem = 614 nm, Fig. 4a, shows the absorption bands of the ligands and weak bands 326 
corresponding to the metal absorption at 395 nm (5L6 ← 7F0), 416 nm (5D3 ← 7F0), 465 nm (5D2 ← 327 
7F0) and at 536 nm (5D1 ←7F0). The emission spectrum of this compound measured in the metal 328 
absorption energy range (λex = 395 nm, Fig. 4b) is a lot less intense and also shows ligand centred 329 
bands because direct metal absorption is less efficient compared to a ligandto-metal energy transfer 330 
process. 331 
The emission spectrum of the Gd(III) complex S-2 (Fig. 4c, λex = 300 nm) reveals only a broad band 332 
arising from the organic ligands, centred at 375 nm. The corresponding excitation spectrum (Fig. 4c, 333 
λem = 375 nm) exhibits two absorption bands, one at 284 nm and the other at 337 nm. The spectrum 334 
recorded at 77 K (Fig. S5,† red spectrum) presents two bands assigned to the emission from the singlet 335 
(365 nm, 27 397 cm−1) and triplet (417 nm, 23 981 cm−1) excited states. To investigate which of the 336 
ligands enhances the luminescence of the lanthanides we also recorded the emission spectra of both 337 
ligands. The emission spectrum of S-naproxen (Fig. S6†) shows a broad band from 330 to 422 nm with 338 
a maximum at 353 nm, on the other hand, the emission spectrum of phen (Fig. S7†) shows a five 339 
maxima emission from 337 to 500 nm with the highest maximum at 361 nm. With this it seems that the 340 
energy transfer process should be enhanced by the ligand phen. The emission spectrum of the Tb(III) 341 
complex S-3 (Fig. 4d, λex = 350 nm) displays metal-centred luminescence due to the 5D4 → 7FJ 342 
transitions centred at 480 nm ( J = 6), 538 nm ( J = 5), 575 nm ( J = 4) and at 609 nm ( J = 3). Only 343 
absorption bands from the ligands are observed in the excitation spectrum. 344 
The emission spectrum of the Dy(III) complex S-4 measured at λex = 350 nm (Fig. 4e) shows the 345 
characteristic Dy(III) emission profile with two main transitions 7F9/2 → 6H15/2 and 7F9/2 → 9H13/2 346 
at 479 and 573 nm, respectively. The antenna effect in this complex seems to be less efficient compared 347 
to that of compounds S-1 and S-3 since a residual ligand emission band appears below 470 nm. The 348 
corresponding excitation spectrum (λem = 478 nm, Fig. 4e) displays a broad band between 400–450 nm 349 
assigned to π–π* absorption transitions. 350 
 351 
Circular dichroism 352 
Solid state electronic circular dichroism (ECD) spectra of complexes S- and R-1, 3 and 4 are shown in 353 
Fig. 5 and display Cotton effects in the ∼240–360 nm range due to the chirality of the complexes.31 354 
Ligand-centred electronic transitions display only very weak ECD bands, revealing low dissymmetry in 355 
the ligand arrangement around the metal centres. Thanks to the low rotatory strength of transitions 356 
associated with phenanothroline and naproxen ligands, some contributions of the usually weak f–f 357 
transitions are observed in all the cases giving rise to the emergent spectral manifolds. This situation is 358 
similar to the one previously observed in the case of analogous 2-phenylpropionic acid-based 359 
complexes.29 360 
 361 
CPL measurements 362 
In view of chiral and luminescence properties of this family of complexes, circularly polarized 363 
luminescence (CPL) measurements were performed on visible-energy emitting compounds S- and R-1, 364 
3 and 4. Only S- and R-1 compounds display CPL signals with low intensity emission bands (Fig. 6), 365 
centred at 593 nm and 617 nm assigned to 5D0 → 7F1 and 5D0 → 7F2 transitions, respectively. As a 366 
consequence of the low intensity of these bands, it has only been possible to quantify the dissym-metry 367 
factor for the 5D0 → 7F2 transition with glum values equal to ±1 × 10−3, positive for the R-enantiomer. 368 
This value is similar to the one observed for the analogous 2-phenylpropionic acid-based Eu complex,29 369 
but lower than other polynuclear Eu compounds.33,62,63 In order to study the stabilization of these 370 
complexes in solution, CPL measurements have been performed on CH2Cl2 dissolution but no emission 371 
signals were observed. Therefore, based on these results, it seems that the organic ligands dissociate 372 
from the complex in solution. 373 
374 
Conclusions 375 
The use of the R- and S-enantiomerically pure species of 2-(6-methoxi-2-naphthyl)propionic acid and 376 
the 1,10-phenantroline auxiliary ligand has led to homodinuclear chiral compounds R- or S-1–4 with the 377 
formula [Ln2(R/S-L)6(phen)2]·3DMF·H2O [Ln(III) = Eu (1), Gd (2), Tb (3) and Dy (4)]. In the 378 
syntheses of the new compounds, we have used a straightforward room temperature and pressure 379 
procedure. 380 
From the magnetic studies recorded on these complexes, the fitting by the Heisenberg–Dirac–Van Vleck 381 
(HDVV) spin Hamiltonian of the χMT product vs. T of Gd(III) compounds reveals a weak 382 
antiferromagnetic interaction between the two Ln(III) within the dinuclear unit. The Dy(III) compounds 383 
R- and S-4 display field-induced slow relaxation of the magnetization with discrete effective energy 384 
barrier values. 385 
Moreover, the solid state luminescence study has revealed sensitization of the f–f Ln(III) transitions in 386 
the visible region for compounds R- and S-1 [Eu(III)], R- and S-3 [Tb(III)], and R- and S-4 [Dy(III)]. 387 
Taking advantage of the chiral and emission properties, CPL measurements have been performed on the 388 
visible emitting compounds. For the Eu(III) complexes R- and S-1 the analysis of the data has yielded a 389 
glum = ± 1 × 10−3. 390 
Thus, compounds R- and S-1, 3 and 4 display luminescence and chiral properties and can be considered 391 
as multifunctional complexes. Furthermore, field-induced SMM properties have been observed for R- 392 
and S-4. To the best of our knowledge, compounds R- and S-4 are the first examples of homodinuclear 393 
Dy(III) complexes in which chiral, emissive and SMM properties are described. 394 
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Legends to figures 502 
 503 
Fig. 1 (a) Partially labelled plot of the dinuclear compound S-3. (b) Coordination polyhedra of Tb(III) 504 
ions in compound S-3. 505 
 506 
Fig. 2 (a) χMT vs. T plot of complexes S-1–4. Solid lines represent the theoretical fit in compounds S-1 507 
and S-2. (b) M vs. H plot of compounds S-1–4. 508 
 509 
Fig. 3 Representation of the frequency dependence of the out-of-phase component of the ac 510 
susceptibility under a 0.2 T dc field (a), Argand plots (b) and magnetization relaxation time, ln(τ) vs. 511 
T−1 (c) for S-4. Red line represents the fitting using Orbach and direct relaxation processes. 512 
 513 
Fig. 4 Solid-state excitation (dashed line) and emission (solid line) spectra recorded at r. t. for 514 
complexes S-1 (a) and (b), S-2 (c), S-3 (d), and S-4 (e). 515 
 516 
Fig. 5 Solid-state ECD spectra for complexes S- and R-1 (a), 3 (b) and 4 (c). 517 
 518 
Fig. 6 Solid-state CPL spectra for complexes S- and R-1. 519 
 520 
521 































Table 1 Selected bond distances (Å) and angles (°) for R/S-1, 3 and 4 553 
 554 
 555 
